Related Experiment Video
Updated: Jun 28, 2026

11:22
Automated Robotic Liquid Handling Assembly of Modular DNA Devices
Published on: December 1, 2017
Managing laboratory automation in a changing pharmaceutical industry
1Quality Control Laboratories Eli Lilly and Company Lilly Corporate Center Indianapolis IN 46285 USA.
The Journal of Automatic Chemistry
|January 1, 1995
Summary
Implementing laboratory automation, including robotics and automated workstations, is crucial for pharmaceutical quality control to meet healthcare reform demands. This study details challenges and outcomes of automation projects in a pharmaceutical setting.
Area of Science:
- Pharmaceutical industry
- Laboratory management
- Quality Control
Background:
- Healthcare reform and regulatory demands necessitate increased efficiency and cost reduction in pharmaceutical laboratories.
- Laboratories face pressure to improve analytical output, customer service, and reduce cycle times while maintaining accuracy.
- Automation, including robotics and automated workstations, is a key strategy for meeting these evolving laboratory demands.
Purpose of the Study:
- To present the rationale, implementation, outcomes, and lessons learned from automated system projects.
- To address the management challenges associated with establishing automated laboratory systems.
- To provide insights into the successful integration of automation within pharmaceutical Quality Control (QC) laboratories.
Main Methods:
- Case study analysis of several automated systems implemented in Eli Lilly's Quality Control Laboratories.
- Examination of project selection rationale, implementation processes, and encountered obstacles.
- Evaluation of project outcomes and identification of key learning points.
Main Results:
- Successful implementation of automated systems in pharmaceutical QC labs requires careful planning and management.
- Key challenges include hardware selection, budget justification, validation, training, and ongoing support.
- Automation can lead to improved efficiency, reduced costs, and enhanced laboratory performance.
Conclusions:
- Automation is essential for pharmaceutical laboratories to adapt to regulatory and market pressures.
- Addressing management challenges proactively is critical for successful automation implementation.
- Lessons learned from real-world projects provide valuable guidance for future laboratory automation initiatives.
Related Concept Videos
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...

